Humanized anti-CD4 antibody with immunosuppressive properties

Details for Australian Patent Application No. 2004222089 (hide)

Owner Biotest AG

Inventors Jonuleit, Helmut; Wijdenes, John

Agent Davies Collison Cave

Pub. Number AU-B-2004222089

PCT Pub. Number WO2004/083247

Priority 03290725.5 21.03.03 EP; 03290942.6 16.04.03 EP

Filing date 19 March 2004

Wipo publication date 30 September 2004

Acceptance publication date 2 December 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/083247 Priority application(s): WO2004/083247

31 July 2008 Amendment Made

  The nature of the amendment is: Add coinventor name to read Jonuleit, Helmut

2 December 2010 Application Accepted

  Published as AU-B-2004222089

31 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004222090-Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators

2004222079-Polymerisation and oligomerisation catalysts